Facial Erythema Treatment Market, By Drug Type (Emollients, Corticosteroids, Antihistamines, Antifungal, Antibiotics, and Calcineurin Inhibitors), By Product Type, By Disease Type, By Distribution Channel, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4509
|
Published Date
November 2025
|
Pages
365
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
The Facial Erythema Treatment Market size was valued at US$ 198 Million in 2024, expanding at a CAGR of 5.6% from 2025 to 2032.
Facial erythema treatment encompasses a range of therapeutic approaches designed to manage chronic or episodic facial redness resulting from rosacea, photosensitivity, vascular dilation, and other inflammatory skin conditions. The market comprises prescription topicals, device-based therapies, oral anti-inflammatories, and advanced dermatological procedures that aim to reduce visible redness while strengthening the skin barrier. Market growth is driven by the rising global prevalence of rosacea and the increasing demand for cosmetic skin rejuvenation, particularly among younger consumers seeking noninvasive aesthetic solutions. According to the World Health Organization (WHO), skin diseases affect over 1.9 billion people globally, with rosacea impacting an estimated 415 million individuals, highlighting the significant treatment need. Innovations such as next-generation topical agents with enhanced vascular targeting, as well as multifunctional devices that combine cooling, vascular modulation, and LED-based—supported by AI-driven diagnostics and ingredient innovation—is shaping market dynamics. However, treatment variability, high procedural costs, and the lack of long-term solutions continue to limit adoption in cost-sensitive markets.
Facial Erythema Treatment Market- Market Dynamics
Rising Public Awareness of Skin Health Drives Market Growth
The increasing public awareness of skin health and the cosmetic effects of facial erythema is a key driver of the Facial Erythema Therapeutics Market. Educational campaigns, social media initiatives, and dermatology programs have enhanced patient understanding of conditions like rosacea, leading to earlier diagnoses and improved treatment adherence. According to the National Rosacea Society, awareness efforts have contributed to a 25% rise in rosacea diagnoses in the United States over the past five years, boosting the number of patients seeking medical care. Supporting this trend, Galderma launched an advanced topical therapy for facial erythema in March 2024, achieving a 40% reduction in redness within four weeks. This demonstrates how heightened awareness, coupled with innovative treatments, is driving patient demand and fueling market growth.
Facial Erythema Treatment Market- Segmentation Analysis:
The worldwide market is segmented on the basis of Drug Type, Product Type, Disease Type, Distribution Channel, End User, and Region.
Based on Drug Type: Antibiotics remain a major revenue driver in the Facial Erythema Treatment Market due to their proven efficacy in managing inflammatory skin conditions such as rosacea, which often cause persistent facial redness. Drugs like doxycycline and minocycline offer both antimicrobial and anti-inflammatory benefits, making them widely prescribed in clinical practice. According to a 2023 market study, the antibiotics segment generated approximately USD 617.5 million globally. In a significant development, Journey Medical Corporation received FDA approval in November 2024 for Emrosi (DFD-29), an oral antibiotic therapy for rosacea targeting both lesions and facial redness, highlighting ongoing innovation in this category.
Based on Product Type: Topical treatments hold a substantial share of the Facial Erythema Treatment Market due to the widespread use of prescription and over-the-counter creams such as brimonidine and metronidazole. These treatments are convenient, cost-effective, and clinically effective in reducing facial redness, making them a preferred option among physicians. Sustained physician recommendations, along with growing consumer preference for non-invasive therapies, continue to drive adoption and revenue growth across developed and emerging markets. For example, in 2025 (reporting 2024 figures), Galderma reported net sales of USD 4.41 billion, up 9.3% year-on-year on a constant currency basis, with its Dermatological Skincare segment—including topical rosacea treatments—growing 10.7% in 2024.
Facial Erythema Treatment Market- Geographical Insights
North America holds a strong position in the Facial Erythema Treatment Market due to several key factors, including high government healthcare expenditure on pharmaceuticals and medical devices, as well as widespread societal awareness of skin health. The National Rosacea Society (NRS) estimates that around 16 million Americans were affected by rosacea in 2018. Such trends are driving more patients with facial erythema to seek clinical care, thereby expanding the market in the region. Additionally, the presence of numerous international companies collaborating with major hospital chains further fuels market growth.
The United States is a leading revenue generator in the North American facial erythema treatment market, supported by a high prevalence of rosacea, a well-developed dermatology care infrastructure, and strong patient adoption of prescription and aesthetic therapies. According to the NRS, rosacea affects an estimated 16 million Americans, sustaining demand for topical vasoconstrictors, anti-inflammatory medications, and laser-based therapies. The growing adoption of advanced laser devices in dermatology clinics further strengthens the market. For instance, in 2023, Candela Medical launched its upgraded Vbeam Prima pulsed-dye laser platform in the U.S., offering improved vascular lesion clearance. The platform has seen rising utilization among dermatologists, directly contributing to increased demand for erythema-focused treatment solutions in the country.
Facial Erythema Treatment Market- Competitive Landscape:
The facial erythema treatment market is moderately competitive, driven by pharmaceutical and dermatology companies innovating in topical therapies, laser devices, and combination treatment options. Key players include Galderma, Allergan Aesthetics (AbbVie), Leo Pharma, Bausch Health, and Candela Corporation, all of which invest heavily in product development and clinical advancements to strengthen their market positions. Competition is focused on improving treatment efficacy, minimizing side effects, and developing faster-acting formulations for conditions such as rosacea-related erythema. For example, in May 2023, Galderma reported positive clinical data for Epsolay® (benzoyl peroxide 5% cream) and continued expansion of Rhofade® (oxymetazoline 1% cream) into new markets, reinforcing its leadership in facial redness management. Market dynamics are further shaped by ongoing R&D investment, broader product indications, and strategic collaborations with dermatology clinics and aesthetic centers.
Recent Developments:
- In April 2025, the Kesty Redness Scale (KRS) was introduced as a validated tool for objectively assessing facial erythema severity in clinical settings. By providing standardized, quantitative evaluations, the KRS allows dermatologists to more effectively monitor patient improvement and compare treatment outcomes across therapies, enhancing overall rosacea management.
- In March 2025, Journey Medical released Phase 3 trial results for Emrosi (DFD-29), an oral minocycline-based rosacea treatment. The study demonstrated superior efficacy and safety compared to doxycycline and placebo, with significant improvements in facial erythema and inflammatory lesions, positioning Emrosi as a potential new standard for rosacea therapy.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL FACIAL ERYTHEMA TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- GlaxoSmithKline plc (GSK)
- Sol-Gel Technologies Ltd.
- Cynosure, Inc.
- Mayne Pharma Group Limited
- Astellas Pharma Inc.
- Galderma
- AbbVie Inc.
- Bausch Health Companies Inc.
- Aclaris Therapeutics, Inc
- Merck & Co., Inc.
- Alma Lasers
- Cutera, Inc.
- Candela Corporation
- LEO Pharma A/S
- Novartis International AG
- Bayer AG
- Pfizer Inc.
- Sanofi S.A
- SkinCeuticals
- EltaMD
- Others
GLOBAL FACIAL ERYTHEMA TREATMENT MARKET, BY DRUG TYPE- MARKET ANALYSIS, 2019 - 2032
- Emollients
- Corticosteroids
- Antihistamines
- Antifungal
- Antibiotics
- Calcineurin Inhibitors
GLOBAL FACIAL ERYTHEMA TREATMENT MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Topical Treatments
- Laser Therapies
- Oral Medications
- Others
GLOBAL FACIAL ERYTHEMA TREATMENT MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019 - 2032
- Papulopustular (PPR)
- Erythematotelangiectatic (ETR)
- Phymatous
- Ocular
GLOBAL FACIAL ERYTHEMA TREATMENT MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
GLOBAL FACIAL ERYTHEMA TREATMENT MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Homecare
- Dermatology Clinics
GLOBAL FACIAL ERYTHEMA TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Facial Erythema Treatment Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Facial Erythema Treatment Market Snippet by Drug Type
2.1.2. Facial Erythema Treatment Market Snippet by Product Type
2.1.3. Facial Erythema Treatment Market Snippet by Disease Type
2.1.4. Facial Erythema Treatment Market Snippet by Distribution Channel
2.1.5. Facial Erythema Treatment Market Snippet by End User
2.1.6. Facial Erythema Treatment Market Snippet by Country
2.1.7. Facial Erythema Treatment Market Snippet by Region
2.2. Competitive Insights
3. Facial Erythema Treatment Key Market Trends
3.1. Facial Erythema Treatment Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Facial Erythema Treatment Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Facial Erythema Treatment Market Opportunities
3.4. Facial Erythema Treatment Market Future Trends
4. Facial Erythema Treatment Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Facial Erythema Treatment Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Facial Erythema Treatment Market Landscape
6.1. Facial Erythema Treatment Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Facial Erythema Treatment Market – By Drug Type
7.1. Overview
7.1.1. Segment Share Analysis, By Drug Type, 2024 & 2032 (%)
7.1.2. Emollients
7.1.3. Corticosteroids
7.1.4. Antihistamines
7.1.5. Antifungal
7.1.6. Antibiotics
7.1.7. Calcineurin Inhibitors
8. Facial Erythema Treatment Market – By Product Type
8.1. Overview
8.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
8.1.2. Topical Treatments
8.1.3. Laser Therapies
8.1.4. Oral Medications
8.1.5. Others
9. Facial Erythema Treatment Market – By Disease Type
9.1. Overview
9.1.1. Segment Share Analysis, By Disease Type, 2024 & 2032 (%)
9.1.2. Papulopustular (PPR)
9.1.3. Erythematotelangiectatic (ETR)
9.1.4. Phymatous
9.1.5. Ocular
10. Facial Erythema Treatment Market – By Distribution Channel
10.1. Overview
10.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
10.1.2. Hospital Pharmacies
10.1.3. Online Pharmacies
10.1.4. Retail Pharmacies
11. Facial Erythema Treatment Market – By End User
11.1. Overview
11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
11.1.2. Hospitals
11.1.3. Homecare
11.1.4. Dermatology Clinics
12. Facial Erythema Treatment Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
12.2.1. Overview
12.2.2. Facial Erythema Treatment Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.2.4. North America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.2.5. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.6. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.2.7. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Facial Erythema Treatment Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.18. Rest of Europe
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.18.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.3.18.4. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.18.5. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.3.18.6. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Facial Erythema Treatment Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Facial Erythema Treatment Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Facial Erythema Treatment Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Facial Erythema Treatment Industry
13.1. Competitive Benchmarking
13.1.1. Competitive Dashboard
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. GlaxoSmithKline plc (GSK)
13.2.2. Sol-Gel Technologies Ltd.
13.2.3. Cynosure, Inc.
13.2.4. Mayne Pharma Group Limited
13.2.5. Astellas Pharma Inc.
13.2.6. Galderma
13.2.7. AbbVie Inc.
13.2.8. Bausch Health Companies Inc.
13.2.9. Aclaris Therapeutics, Inc
13.2.10. Merck & Co., Inc.
13.2.11. Alma Lasers
13.2.12. Cutera, Inc.
13.2.13. Candela Corporation
13.2.14. LEO Pharma A/S
13.2.15. Novartis International AG
13.2.16. Bayer AG
13.2.17. Pfizer Inc.
13.2.18. Sanofi S.A
13.2.19. SkinCeuticals
13.2.20. EltaMD
13.2.21. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL FACIAL ERYTHEMA TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- GlaxoSmithKline plc (GSK)
- Sol-Gel Technologies Ltd.
- Cynosure, Inc.
- Mayne Pharma Group Limited
- Astellas Pharma Inc.
- Galderma
- AbbVie Inc.
- Bausch Health Companies Inc.
- Aclaris Therapeutics, Inc
- Merck & Co., Inc.
- Alma Lasers
- Cutera, Inc.
- Candela Corporation
- LEO Pharma A/S
- Novartis International AG
- Bayer AG
- Pfizer Inc.
- Sanofi S.A
- SkinCeuticals
- EltaMD
- Others
GLOBAL FACIAL ERYTHEMA TREATMENT MARKET, BY DRUG TYPE- MARKET ANALYSIS, 2019 - 2032
- Emollients
- Corticosteroids
- Antihistamines
- Antifungal
- Antibiotics
- Calcineurin Inhibitors
GLOBAL FACIAL ERYTHEMA TREATMENT MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Topical Treatments
- Laser Therapies
- Oral Medications
- Others
GLOBAL FACIAL ERYTHEMA TREATMENT MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019 - 2032
- Papulopustular (PPR)
- Erythematotelangiectatic (ETR)
- Phymatous
- Ocular
GLOBAL FACIAL ERYTHEMA TREATMENT MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
GLOBAL FACIAL ERYTHEMA TREATMENT MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Homecare
- Dermatology Clinics
GLOBAL FACIAL ERYTHEMA TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
